Schizophrenia News and Research

Latest Schizophrenia News and Research

EMA accepts to evaluate Vanda's MAA for oral iloperidone tablets

Vanda Pharmaceuticals Inc. announced today that the European Medicines Agency (EMA) accepted for evaluation Vanda's Marketing Authorization Application (MAA) for oral iloperidone tablets.

27 Jul 2011

NeurOp receives NIH grant to support research program for ischemia

NeurOp, Inc., a biopharmaceutical company developing new treatments for central nervous system disorders, today announced that the National Institutes of Health (NIH) has awarded the company a $3 million grant to support its research program for ischemia.

27 Jul 2011

Drugs targeting specific brain region could help people with schizophrenia manage daily life, study shows

A new study has identified the neural mechanism that hinders reward identification and decision-making in people suffering from schizophrenia, highlighting the need for more effective drug therapies to help people with the disease manage their daily lives.

25 Jul 2011

CDR recommends reimbursement for schizophrenia drug, ABILIFY

Bristol-Myers Squibb Canada is pleased to announce that the Common Drug Review (CDR) has recognized the value of ABILIFY® (aripiprazole) for the treatment of schizophrenia and schizoaffective disorders by recommending it be reimbursed by provincial drug plans for patients who have a contraindication to less-expensive antipsychotic agents or who have failed a trial of less expensive antipsychotic agents due to intolerance or lack of response.

22 Jul 2011

State news: Florida effort could cost consumers $60 million in rebates

The JMH Health Plan, the insurance wing of the Jackson Health System, has become a huge money-loser that must be fixed quickly, board members were told Thursday. So far this year, the plan has lost $30.4 million — almost half of the $71.7 million that Jackson Health System has lost for the entire fiscal year.

22 Jul 2011

Intense visual stimulation renders nerve cells more receptive to subsequent learning

Dr. Ed Ruthazer is a mapmaker but, his landscape is the developing brain - specifically the neuronal circuitry, which is the network of connections between nerve cells. His research at The Montreal Neurological Institute and Hospital - The Neuro at McGill University, reveals the brain as a dynamic landscape where connections between nerves are plastic, changing and adapting to the demands of the environment.

21 Jul 2011

Common cancer drug alleviates symptoms associated with schizophrenia

Researchers have revealed the molecular pathway that is affected during the onset of schizophrenia and successfully alleviated symptoms of the illness in mice, using a commonly used cancer drug.

21 Jul 2011

Johnson & Johnson second quarter sales increase 8.3% to $16.6 billion

Johnson & Johnson today announced sales of $16.6 billion for the second quarter of 2011, an increase of 8.3% as compared to the second quarter of 2010.

19 Jul 2011

Simple lifestyle changes could prevent half of all Alzheimer's disease cases

Over half of all Alzheimer's disease cases could potentially be prevented through lifestyle changes and treatment or prevention of chronic medical conditions, according to a study led by Deborah Barnes, PhD, a mental health researcher at the San Francisco VA Medical Center.

19 Jul 2011

Ultrasound can detect risk of psychiatric disorders in premature infants

Infants born prematurely are at risk for injuries to the white and gray matter of the brain that affect cortical development and neural connectivity. Certain forms of these injuries can be detected in the neonatal period using ultrasound, according to Columbia University Medical Center researchers.

15 Jul 2011

Neuralstem receives U.S. patent allowance for three new neurogenic compounds

Neuralstem, Inc. announced that it has received notice of allowance for U.S. Patent Applications 12/939,897 and 12/939,914 entitled: "Compositions to Effect Neuronal Growth."

15 Jul 2011

Longer looks: Penalties for doctors who keep patients waiting

When she makes a doctor's appointment, Cherie Kerr makes it clear that she better not be kept waiting long. She said she usually tries to schedule the first appointment of the day, or the first one after lunch. But if the doctor is going to be late, she insists the staff give her a call -- lest the office be billed for her time in the waiting room.

15 Jul 2011

Young investigators to receive Brain & Behavior Research Foundation awards

Brain & Behavior Research Foundation will honor five outstanding researchers at the Annual Klerman and Freedman Awards event in New York City.

15 Jul 2011

HIV patients with mental illness can benefit from APRN care management

In a four-year study, researchers at the University of Pennsylvania have found that assigning adults with serious mental health illness who are HIV positive to the care of advanced practice nurses (APRN) to help navigate the health care system and maintain adherence to drug regimens reduced depression and improved their overall physical health, indicating that healthcare policy should be revamped to provide this support.

12 Jul 2011

Study may help explain why antipsychotic drugs can promote overeating, weight gain

Research to be presented at the upcoming annual meeting of the Society for the Study of Ingestive Behavior (SSIB), the foremost society for research into all aspects of eating and drinking behavior, may explain why some antipsychotic drugs can promote overeating, weight gain, and insulin resistance.

12 Jul 2011

Scientists identify de novo mutations linked to schizophrenia

De novo mutations - genetic errors that are present in patients but not in their parents - are more frequent in schizophrenic patients than in normal individuals, according to an international group of scientists led by Dr. Guy A. Rouleau of the University of Montreal and CHU Sainte-Justine Hospital.

11 Jul 2011

Global research initiative to improve health care for people with MNS disorders

Mental health experts are calling for a greater world focus on improving access to care and treatment for mental, neurological, and substance use (MNS) disorders, as well as increasing discoveries in research that will enable this goal to be met.

7 Jul 2011

Individuals with anorexia nervosa have elevated mortality rate

Individuals who have eating disorders have an elevated mortality rate, especially those with anorexia nervosa (AN), according to a meta-analysis of previous studies, reported in the July issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

5 Jul 2011

Nicotine receptors play crucial role in social interaction

If you think nicotine receptors are only important to smokers trying to kick the tobacco habit, think again. New research published in the FASEB Journal (http://www.fasebj.org) suggests that these receptors also play an important role in social interaction and the ability to choose between competing motivations.

1 Jul 2011

Positive topline results from Alkermes ALKS 9070 phase 1b study for schizophrenia

Alkermes, Inc. today announced positive topline results from a phase 1b, double-blind, randomized, placebo-controlled study of ALKS 9070 in patients with schizophrenia.

30 Jun 2011

Schizophrenia News and Research

Latest Schizophrenia News and Research

EMA accepts to evaluate Vanda's MAA for oral iloperidone tablets

NeurOp receives NIH grant to support research program for ischemia

Drugs targeting specific brain region could help people with schizophrenia manage daily life, study shows

CDR recommends reimbursement for schizophrenia drug, ABILIFY

State news: Florida effort could cost consumers $60 million in rebates

Intense visual stimulation renders nerve cells more receptive to subsequent learning

Common cancer drug alleviates symptoms associated with schizophrenia

Johnson & Johnson second quarter sales increase 8.3% to $16.6 billion

Simple lifestyle changes could prevent half of all Alzheimer's disease cases

Ultrasound can detect risk of psychiatric disorders in premature infants

Neuralstem receives U.S. patent allowance for three new neurogenic compounds

Longer looks: Penalties for doctors who keep patients waiting

Young investigators to receive Brain & Behavior Research Foundation awards

HIV patients with mental illness can benefit from APRN care management

Study may help explain why antipsychotic drugs can promote overeating, weight gain

Scientists identify de novo mutations linked to schizophrenia

Global research initiative to improve health care for people with MNS disorders

Individuals with anorexia nervosa have elevated mortality rate

Nicotine receptors play crucial role in social interaction

Positive topline results from Alkermes ALKS 9070 phase 1b study for schizophrenia

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Schizophrenia News and Research

Latest Schizophrenia News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Newsletters you may be interested in